Streetbeat News

Price Targets

TX

B of A Securities analyst Caio Ribeiro upgraded Ternium (NYSE:TX) from Neutral to Buy and set a price target of $47.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 12:05 pm

ELBM

HC Wainwright & Co. analyst Heiko Ihle has maintained a Buy rating on Electra Battery Materials (NASDAQ:ELBM) but has reduced the price target from $2.5 to $1.6.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 12:04 pm

IMGN

Analysts have recently updated their ratings for Immunogen (NASDAQ:IMGN), with 6 analysts offering an average price target of $22.5, which is 39.32% higher than the current price of $16.15. The new average target represents an 8.85% increase from the previous target of $20.67. Over the past quarter, there have been 3 bullish, 1 somewhat bullish, and 2 indifferent ratings, with no bearish sentiments. Analysts typically review stocks quarterly or after major company events, basing their ratings on financial predictions and company performance.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 12:00 pm

CHGG

Chegg (NYSE:CHGG) has received 7 indifferent and 1 somewhat bearish analyst ratings within the last quarter, with no bullish or bearish ratings. The average 12-month price target among 8 analysts is $10.0, with a high of $12.00 and a low of $9.00, representing a 21.57% decrease from the previous average price target of $12.75.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 12:00 pm

MS

Morgan Stanley (NYSE:MS) has received 11 analyst ratings in the last quarter with an average price target of $93.47, representing an upside from the current price of $79.8. The ratings include 1 bullish, 6 somewhat bullish, and 4 indifferent. The new average price target is a 7.85% decrease from the previous target of $101.43. Analyst ratings are opinions based on financial analysis and are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 12:00 pm

KRTX

Over the past 3 months, 8 Wall Street analysts have provided ratings for Karuna Therapeutics (NASDAQ:KRTX), with an average price target of $275.5, which is higher than the current price of $179.73. All 8 analysts are bullish or somewhat bullish, with no indifferent, somewhat bearish, or bearish ratings. The current average price target has decreased by 1.69% from the previous target of $280.25.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 12:00 pm

RYAN

Within the last quarter, Ryan Specialty Hldgs (NYSE:RYAN) received 1 somewhat bullish and 3 indifferent ratings from analysts, with no bullish or bearish ratings. The average price target is $52.5, representing an upside from the current price of $44.42. This target has slightly decreased by 0.32% from the previous target of $52.67. Analyst ratings are opinions based on financial analysis and are not guarantees of performance.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 12:00 pm

CAT

Over the past 3 months, 4 Wall Street analysts have provided ratings on Caterpillar (NYSE:CAT), with an average price target of $284.75, representing an implied upside from the current price of $252.49. The consensus includes 2 bullish, 1 somewhat bullish, and 1 indifferent rating. This average price target is a 6.33% decrease from the previous target of $304.00. Analysts rate stocks to predict performance, and these ratings are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 12:00 pm

ARVN

Guggenheim analyst Michael Schmitz has upgraded Arvinas (NASDAQ:ARVN) from Neutral to Buy and set a price target of $40 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 11:49 am

SID

B of A Securities analyst Caio Ribeiro upgraded Companhia Siderurgica (NYSE:SID) from Underperform to Buy and set a price target of $4.1.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 11:48 am